Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Utility of Combined Immunohistochemical Staining for AMBRA1 and Loricrin for Improving the Pathologic Diagnosis of High-Grade Dysplastic Nevi.
Journal: The American Journal of dermatopathology
Published: June 26, 2026
Metastatic malignant cylindroma arising on a background of digenic inheritance of BRCA2 and CYLD pathogenic variants targeted with PARP inhibition.
Journal: Clinical and experimental dermatology
Published: December 04, 2024
YAP1-NUTM1 fusions are infrequent in porocarcinomas arising in a cohort including immunocompromised patients.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 14, 2024
Novel microsatellite instability test of sebaceous tumours to facilitate low-cost universal screening for Lynch syndrome.
Journal: Clinical and experimental dermatology
Published: October 08, 2024
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma.
Journal: The British journal of dermatology
Published: July 06, 2023
Squamous cell carcinoma and MYH9-associated elastin aggregation (MALTA) syndrome.
Journal: Clinical and experimental dermatology
Published: December 11, 2022
Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018.
Journal: Journal of the American Academy of Dermatology
Published: October 24, 2022
Melanocytic matricoma: A report of three cases, review of the literature, and suggestion of a new terminology.
Journal: Journal of cutaneous pathology
Published: April 28, 2021
Developmental cell programs are co-opted in inflammatory skin disease.
Journal: Science (New York, N.Y.)
Published: December 21, 2019
Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome.
Journal: Nature communications
Published: April 23, 2019
Squamous Cell Carcinoma and Multiple Familial Trichoepitheliomas: A Recurrent Association.
Journal: Acta dermato-venereologica
Published: July 05, 2018
Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial.
Journal: JAMA dermatology
Published: June 30, 2018
Last Updated: 09/26/2026